Zepp Health (ZEPP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jan, 2026Executive summary
Q3 2024 revenue was $42.5 million, down 48.9% year-over-year, with 0.7 million units shipped, mainly due to lower Xiaomi and self-branded product sales amid supply constraints and macroeconomic weakness.
Achieved highest sequential growth in self-branded sales for 2024, up 9.9% quarter-over-quarter, contributing over 95% of total revenue, driven by new launches like the T-Rex 3 smartwatch.
Gross margin reached a record 40.6%, up from 33.9% a year ago, marking the sixth consecutive quarter of expansion.
Net loss attributable to Zepp was $13.3 million in Q3 2024; adjusted net loss was $12.6 million.
Ongoing product innovation and ecosystem expansion with launches like Amazfit Helio Ring, Up earbuds, and new marketing partnerships.
Financial highlights
Q3 2024 revenue was $42.5 million, down from $83.1 million in Q3 2023; units shipped fell to 0.7 million from 2.8 million.
Gross margin: 40.6% in Q3 2024, the highest in company history.
Operating costs for Q3 were $29 million, including a $1 million foreign exchange loss; excluding FX, costs were $28 million.
R&D expenses: $10.9 million (25.6% of revenue), selling/marketing: $11.9 million (28.0% of revenue), G&A: $7.0 million (16.5% of revenue), all up year-over-year.
Cash and cash equivalents stood at $127.7 million as of September 30, 2024, stable sequentially.
Outlook and guidance
Q4 2024 net revenues expected between $55 million and $70 million, with self-branded products projected to contribute over 90% of revenue and grow 29%–65% sequentially.
Anticipates higher Q4 sales due to resolved supply constraints, seasonal demand, and new product launches.
Expects continued margin expansion and improved profitability as cost management and product mix improvements persist.
Focus areas include international expansion, new product releases, and strict cost control.
Plans for a more balanced product launch cadence in 2025, with major product line renewals each quarter.
Latest events from Zepp Health
- Q1 revenue was $38.5M, all from Amazfit, with 10.2% sales growth and improved margin.ZEPP
Q1 202517 Mar 2026 - Q4 2025 revenue up 43% year-over-year, with record gross margin and sharply reduced net loss.ZEPP
Q4 202516 Mar 2026 - Record gross margin and sequential self-branded sales growth offset sharp revenue decline.ZEPP
Q2 202423 Jan 2026 - Q4 revenue surged 40%, but full-year sales fell sharply as Xiaomi-branded sales collapsed.ZEPP
Q4 202417 Dec 2025 - Revenue up 46.2% YoY to $59.4M, net loss narrowed, Q3 guidance at $72–$76M.ZEPP
Q2 202523 Nov 2025 - Q3 2025 revenue up 78.5% to $75.8M, with breakeven income and strong Q4 guidance.ZEPP
Q3 20255 Nov 2025